Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Empirical Ventures Bbi Nominees Limited investment portfolio
Empirical Ventures Bbi Nominees Limited has made numerous investments in companies such as Porpoise Power, Signapse, and Mitorx Therapeutics within the AI sector.
vc
Portfolio
11
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (11)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Barton Blakeley Technologies Limited Barton Blakeley Technologies Limited develops and operates carbon conversion technology that transforms waste carbon dioxide emissions into industrial materials, such as silica nano powders and lead-free glass. The company targets industrial manufacturers in the automotive, aerospace, and chemical sectors seeking sustainable, low-carbon alternatives for products like tires, coatings, and electronics. | CleanTechB2B | Confirmed | 2026-02-26 |
| Healome Therapeutics Ltd HEALOME THERAPEUTICS LTD develops novel treatments for eye conditions, particularly ocular surface diseases and eye trauma, utilizing a fluid-gel material that forms a protective layer over the eye. The company aims to provide solutions for patients suffering from these conditions, including dry eye disease, to address leading causes of preventable blindness. | Healthcare & Life Sciences | Confirmed | 2026-01-10 |
Shareholding changes (13)
Empirical Ventures Bbi Nominees Limited's positions across portfolio companies2026
- A ORDINARY 0 → 1,908
- PRE-SEED 0 → 14,273
Articles (3)
- Barton Blakeley Technologies secures £859.5k seed funding for carbon conversion technology9 May 2026Barton Blakeley Technologies
- Lucida Medical Secures Estimated £7.7m to Advance AI-Powered Prostate Cancer Diagnostics18 Apr 2026Lucida Medical
- 28 Mar 2026